top of page
Home
About Us
Team
Science
Pipelines
Ulcerative Colitis
Atopic Dermatitis
COVID-19
Diabetes
Nonalcoholic fatty liver disease
Gout
Investor Relations
Contact
More
Use tab to navigate through the menu items.
Investor Relations
SEC Filings
Investor Relations
NEWS / EVENTS
Press Release
Events & Presentations
SEC FILINGS
STOCK INFO
GOVERNANCE
Governance Documents
9/29/25
8-K
Current report
html
9/12/25
8-K
Current report
html
9/9/25
10-Q
Quarterly report [Sections 13 or 15(d)]
html
8/27/25
8-K
Current report
html
8/26/25
424B4
Prospectus [Rule 424(b)(4)]
html
8/26/25
424B4
Prospectus [Rule 424(b)(4)]
html
8/26/25
8-K
Current report
html
8/25/25
CERT
*
html
8/25/25
8-A12B
Registration of securities [Section 12(b)]
html
8/12/25
EFFECT
Notice of Effectiveness
html
1
2
3
4
1
...
1
2
3
4
...
4
bottom of page